Epigenomics's total assets for Q3 2022 were $18.97M, a decrease of -8.00% from the previous quarter. DE:ECX total liabilities were $5.04M for the fiscal quarter, a 27.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.